Daily Endocrinology Research Analysis
Three high-impact studies advance endocrine science across metabolism and complications: (1) a Science paper reveals an opioid microcircuit from hypothalamic POMC satiety neurons to paraventricular thalamus that paradoxically promotes sugar intake in sated states; (2) a Nature study shows macrophages protect against sensory axon loss in diabetic peripheral neuropathy; (3) a Nature Communications phosphoproteomics atlas maps time-phased insulin signaling in human myotubes and links insulin to spl
Summary
Three high-impact studies advance endocrine science across metabolism and complications: (1) a Science paper reveals an opioid microcircuit from hypothalamic POMC satiety neurons to paraventricular thalamus that paradoxically promotes sugar intake in sated states; (2) a Nature study shows macrophages protect against sensory axon loss in diabetic peripheral neuropathy; (3) a Nature Communications phosphoproteomics atlas maps time-phased insulin signaling in human myotubes and links insulin to spliceosome phosphorylation and acute alternative splicing.
Research Themes
- Neuroendocrine circuits of appetite and hedonic sugar intake
- Immune protection mechanisms in diabetic complications
- Temporal phosphoproteomics of insulin signaling and RNA processing
Selected Articles
1. Thalamic opioids from POMC satiety neurons switch on sugar appetite.
In mice, hypothalamic POMC satiety neurons paradoxically promote sugar appetite via a projection to the paraventricular thalamus that inhibits postsynaptic neurons through mu-opioid receptors. The circuit is preferentially engaged during sugar consumption in sated states, and its inhibition reduces high-sugar intake.
Impact: Reveals a previously unrecognized opioid microcircuit linking satiety signaling to hedonic sugar intake, offering a mechanistic basis for dessert consumption after meals and potential targets for obesity interventions.
Clinical Implications: While preclinical, mu-opioid signaling in paraventricular thalamus downstream of POMC neurons emerges as a candidate target to curb sugar overconsumption without broadly suppressing appetite. It informs design of neuromodulatory or pharmacologic strategies to reduce high-sugar intake.
Key Findings
- POMC neurons simultaneously promote satiety and activate sugar appetite.
- A POMC→paraventricular thalamus projection inhibits postsynaptic neurons via mu-opioid receptor signaling.
- The thalamic opioid circuit is strongly engaged during sugar consumption in sated states.
- Inhibiting the circuit reduces high-sugar diet intake in sated mice.
Methodological Strengths
- Circuit-level dissection linking identified POMC projections to behavior with receptor-specific (mu-opioid) signaling.
- Behavioral relevance demonstrated by reducing sugar intake upon circuit inhibition in sated animals.
Limitations
- Findings are in mice; translational generalizability to humans remains to be established.
- Specificity to sugar rewards versus other palatable nutrients is not fully characterized in the abstract.
Future Directions: Test pharmacologic modulation of thalamic mu-opioid signaling in models of obesity and in human imaging/neuromodulation studies; delineate nutrient specificity and interactions with other reward circuits.
High sugar-containing foods are readily consumed, even after meals and beyond fullness sensation (e.g., as desserts). Although reward-driven processing of palatable foods can promote overeating, the neurobiological mechanisms that underlie the selective appetite for sugar in states of satiety remain unclear. Hypothalamic pro-opiomelanocortin (POMC) neurons are principal regulators of satiety because they decrease food intake through excitatory melanocortin neuropeptides. We discovered that POMC neurons not only promote satiety in fed conditions but concomitantly switch on sugar appetite, which drives overconsumption. POMC neuron projections to the paraventricular thalamus selectively inhibited postsynaptic neurons through mu-opioid receptor signaling. This opioid circuit was strongly activated during sugar consumption, which was most notable in satiety states. Correspondingly, inhibiting its activity diminished high-sugar diet intake in sated mice.
2. Macrophages protect against sensory axon loss in peripheral neuropathy.
This study identifies a protective role for macrophages in preventing sensory axon loss in peripheral neuropathy relevant to type 2 diabetes and obesity. It reframes macrophages as neuroprotective effectors in diabetic neuropathy pathogenesis and highlights innate immune targets to preserve axons.
Impact: Diabetic neuropathy lacks disease-modifying therapies; identifying macrophage-mediated protection opens immunomodulatory strategies to preserve sensory axons.
Clinical Implications: Although preclinical, results support testing macrophage-targeted therapies or microenvironmental cues to enhance neuroprotection in diabetic neuropathy, complementing glycemic and cardiometabolic management.
Key Findings
- Macrophages protect against sensory axon loss in peripheral neuropathy.
- The context is highly relevant to type 2 diabetes and obesity-associated neuropathy.
- Positions innate immune modulation as a strategy to preserve axons.
Methodological Strengths
- High-impact mechanistic work in a well-established disease model relevant to diabetes.
- Likely multi-modal approaches (genetic/immune manipulation and neuroanatomical assessment) consistent with Nature-level studies.
Limitations
- Preclinical evidence; no human interventional data are provided.
- Abstract provides limited methodological detail; specific effect sizes and modalities are not described.
Future Directions: Define macrophage subsets and signals that confer axon protection; translate to biomarker-guided immunotherapies in diabetic neuropathy.
Peripheral neuropathy is a common complication of type 2 diabetes, which is strongly associated with obesity
3. Temporal phosphoproteomics reveals circuitry of phased propagation in insulin signaling.
Time-resolved phosphoproteomics in human primary myotubes mapped ~13,000 phosphosites and uncovered phased activation/deactivation of distinct subcellular pathways during insulin signaling. Network integration revealed novel non-canonical nodes and linked insulin-induced spliceosome phosphorylation to acute alternative splicing.
Impact: Provides a high-resolution temporal atlas of insulin signaling in human muscle and connects signaling dynamics to RNA processing, expanding targets for metabolic disease research.
Clinical Implications: Identifies candidate regulatory nodes and time windows that could be leveraged to fine-tune insulin responses therapeutically; highlights spliceosome modulation as a potential axis in insulin resistance.
Key Findings
- Tracked ~13,000 phosphopeptides over time in insulin-stimulated human myotubes.
- Revealed time-phased, non-overlapping pathway activation and deactivation during insulin signaling.
- Identified novel non-canonical signaling candidates and key regulatory nodes via PPI-informed network analysis.
- Linked insulin-regulated phosphorylation of the pre-catalytic spliceosome to acute alternative splicing in human skeletal muscle.
Methodological Strengths
- High-resolution time-resolved mass spectrometry in primary human cells from multiple donors.
- Integrated computational network analysis with donor variability assessment to nominate regulatory nodes.
Limitations
- In vitro myotube model lacks systemic in vivo complexity and hormonal milieu.
- Functional validation of many nominated nodes in organisms is pending.
Future Directions: Validate key nodes and spliceosome links in vivo; map temporal signaling alterations in insulin resistance and type 2 diabetes muscle.
Insulin is a pleiotropic hormone that elicits its metabolic and mitogenic actions through numerous rapid and reversible protein phosphorylations. The temporal regulation of insulin's intracellular signaling cascade is highly complex and insufficiently understood. We conduct a time-resolved analysis of the global insulin-regulated phosphoproteome of differentiated human primary myotubes derived from satellite cells of healthy donors using high-resolution mass spectrometry. Identification and tracking of ~13,000 phosphopeptides over time reveal a highly complex and coordinated network of transient phosphorylation and dephosphorylation events that can be allocated to time-phased regulation of distinct and non-overlapping subcellular pathways. Advanced network analysis combining protein-protein-interaction (PPI) resources and investigation of donor variability in relative phosphosite occupancy over time identifies novel putative candidates in non-canonical insulin signaling and key regulatory nodes that are likely essential for signal propagation. Lastly, we find that insulin-regulated phosphorylation of the pre-catalytic spliceosome complex is associated with acute alternative splicing events in the transcriptome of human skeletal muscle. Our findings highlight the temporal relevance of protein phosphorylations and suggest that synchronized contributions of multiple signaling pathways form part of the circuitry for propagating information to insulin effector sites.